BioSpace News Archive

BioCapital

Orgenesis CEO appears as a guest on i24 news network

Orgenesis Inc. announced that Vered Caplan, CEO of Orgenesis, appeared as a guest during the “Israel Business Weekly” segment hosted by Michelle Makori and Eric Landskroner on the i24News Network.

November 13, 2019
·
3 min read
Deals

Merck Snaps Up Preclinical Neurodegenerative Asset in $576 Million Buy

Merck plunked down $576 million to acquire San Diego-based Calporta to gain access to preclinical TRPML1 agonists that are seen as potential treatments for neurodegenerative disorders such as Alzheimer’s or Parkinson’s.

November 13, 2019
·
2 min read
·
Alex Keown
Drug Development

Kiadis to Restructure Months After Acquiring CytoSen Therapeutics

The company will discontinue development of its lead T-cell asset, ATIR101, halt its ongoing Phase III trial and lay off half its staff.

November 13, 2019
·
2 min read
·
Alex Keown
BioForest

Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerative Diseases

The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift.

November 13, 2019
·
3 min read
·
Mark Terry
Is DNA the Data Storage of the Future?

DNA is structurally suited to storing information for extended periods of time, given its half-life of 521 years.

November 13, 2019
·
4 min read
·
David Kirk
Drug Development

GSK’s Nucala Hits the Mark in Phase III HES Trial, Setting Up Potential Approval

HES is a rare group of inflammatory disorders that affects approximately 20,000 people around the world.

November 13, 2019
·
2 min read
·
Alex Keown
BioSpace Global Roundup, Nov. 14

Companies from across the globe provide updates on their business and pipelines.

November 13, 2019
·
8 min read
·
Alex Keown
Arctoris Ltd Strengthens Senior Team to Continue the Development of its On-Demand Drug Discovery Services

Arctoris Ltd announced the appointment of Professor John Mattick AO FAA FTSE FAHMS FRSN HonFRCPA GAICD as a Member of the Board of Directors, and Daniel Thomas PhD LCGI as Head of Discovery Biology.

November 13, 2019
·
3 min read
Business

MaxQ AI® Partners with Arterys to Further Expand Global Access to the Company’s Innovative Intracranial Hemorrhage (ICH) Detection Solutions

Radiologists and care providers around the world will have access to MaxQ AI’s ACCIPIO® ICH and Stroke Platform through Arterys’ cloud-native medical imaging platform.

November 13, 2019
·
4 min read
Drug Development

Esperion Announces Publication in the Journal of the American Medical Association of Bempedoic Acid Phase 3 Study 2 Results

Study 2 Demonstrated that Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP

November 13, 2019
·
9 min read